Breaking News

You are here » Indian-Commodity  :  Economy  :  India's pharma exports declined by 4% till August on pricing pressure


India's pharma exports declined by 4% till August on pricing pressure

India's pharmaceutical exports has registered a negative growth of 4 percent during the first five months of the financial year 2017-18, mainly due to increased regulatory issues along with pricing pressure in global markets. Udaya Bhaskar, the Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), has said that the pharma exports to other countries declined by 7.9 percent during the April-July period, while recovered to 4 percent in the month of August leaving the overall growth at minus 4 percent till August this year.

Bhaskar has pointed out that pricing pressure is one of the factors for decline in exports. He also noted that factors such as import alerts by US Food and Drug Administration (USFDA) on Indian plants, regulatory issues and currency fluctuation, also contributed to downward growth. However, he hoped that the overall exports will recover and come into positive zone for the full year as exports are expected to take an uptick from September.

Pharmexcil's Director General further said that initially, rollout of Goods and Services Tax (GST) regime also created some confusion among the manufacturers leading to stoppage of production by some companies, but now they are seeing some growth. According to statistics, India exported $16.90 billion worth of pharma products during 2015-16 and the same was slightly declined to $16.64 billion in 2016-17.

Related News

View all news

CPI inflation hits 6-month high of 2.92% in April

India's retail inflation based on Consumer Price Index (CPI) continued northward journey for third straight month and inched up to a 6-month high of 2.92% in April 2019 due to a spike in food prices, including......

Indian economy to grow at 7% range in current fiscal: Subramanian

Chief Economic Advisor (CEA) Krishnamurthy V. Subramanian has said  that the Indian economy would grow at 7% range in the current financial year (FY20) powered by the effects of the strong structural......

Banks take 57% haircut in 94 cases resolved in FY19: ASSOCHAM-CRISIL study

A joint study carried out by the industry body Associated Chambers of Commerce & Industry of India (ASSOCHAM) and rating agency CRISIL stated that banks have taken a huge 57% haircut in the 94......

Top News

View all news

SRF, NIIT Technologies and United Bank of India to see some action today

SRF has entered into a definitive agreement to sell its Engineering Plastics Business to DSM, the Life Sciences and Materials Sciences Company in an all-cash transaction, amounting to Rs 320 crore. The......

NIIT Technologies concludes sale of 88.99% stake in ESRI India Technologies

NIIT Technologies has concluded the sale of 88.99% equity shares in ESRI India Technologies, India to Environment Systems Research Institute Inc., USA. Consequent to above sale, ESRI India Technologies,......

United Bank of India to raise Rs 1,500 crore by various means

United Bank of India has received approval to raise equity capital not exceeding Rs 1,500 crore in one or more tranches during the financial year by way of Qualified Institutions Placement, Public Issue,......